标普和纳斯达克内在价值 联系我们

Athenex, Inc. ATNX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
24/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Athenex, Inc. (ATNX) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 23/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
价值
N/A
No coverage
~
未來
40/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
25/100
Debt-to-Equity & liquidity
→ Health
护城河
22/100
→ Income
~
成长
45/100
→ Income
收入
10/100
→ Income

估值概览 — ATNX

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.01
EV/EBITDA0.0
每股数据
EPS (TTM)$-15.13
每股账面价值$0.00
每股营收$15.72
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2015 $-21.77 $13.94M $-50.6M -362.9%
2016 $-41.51 $20.55M $-87.72M -426.8%
2017 $-45.06 $38.04M $-131.17M -344.8%
2018 $-36.40 $89.1M $-117.44M -131.8%
2019 $-33.90 $101.23M $-125.53M -124%
2020 $-34.89 $144.39M $-148.43M -102.8%
2021 $-37.39 $120.18M $-194.31M -161.7%
2022 $-15.13 $102.82M $-98.98M -96.3%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言